identifying and treating high-risk patients in 2023
Published 1 year ago • 699 plays • Length 23:23Download video MP4
Download video MP3
Similar videos
-
13:20
identifying and treating high-risk/mrd positive newly diagnosed multiple myeloma
-
1:20
identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
1:53
karmma-4: ide-cel for newly diagnosed high-risk multiple myeloma
-
2:02
current approaches for the management of patients with high-risk multiple myeloma
-
1:00
multiple myeloma life expectancy
-
1:44:13
unravelling treatment options in multiple myeloma care
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
58:44
treatments available for high risk smoldering myeloma patients
-
4:25
multiple myeloma: what you need to know - mayo clinic
-
59:57
what's available for induction therapy in multiple myeloma
-
5:39
identifying vulnerable patients with multiple myeloma
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
3:57
dr. ghobrial on identifying high risk in smoldering multiple myeloma |dana-farber cancer institute
-
4:40
how do the two approaches to treating high-risk smoldering multiple myeloma (hrsmm) patients differ?
-
1:49
how is high-risk myeloma assessed?
-
29:08
newly diagnosed multiple myeloma, response, bone health, renal health, mrd, survivorship care
-
3:35
proteasome inhibitors in high-risk multiple myeloma
-
1:04:21
know your myeloma therapy: what's available for consolidation therapy?